CCL20 Promotes Ovarian Cancer Chemotherapy Resistance by Regulating ABCB1 Expression.
In conclusion, CCL20 enhanced doxorubicin resistance of OC cells by regulating ABCB1 expression.Key words: CCL20, ovarian cancer, doxorubicin resistance, tumor-promoting, ABCB1.
PMID: 30760665 [PubMed - in process]
Source: Cell Structure and Function - Category: Cytology Authors: Su S, Sun X, Zhang Q, Zhang Z, Chen J Tags: Cell Struct Funct Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Cytology | Japan Health | Ovarian Cancer | Ovaries | Science | Study